Search

Search

Esta página ha sido traducida por una máquina. Otras páginas pueden seguir apareciendo en inglés. View in English

Home
...
Áreas de investigación Ciencias Biomédicas y Clínicas Oncología y carcinogénesis Objetivos moleculares
Áreas de investigación
Ciencias Biomédicas y Clínicas
Oncología y carcinogénesis
Objetivos moleculares
Evaluación preclínica de las células TCR-NK específicas de MAGE-A4 contra tumores sólidos

Evaluación preclínica de las células TCR-NK específicas de MAGE-A4 contra tumores sólidos

Margherita Boieri ¹, Justyna Kmiecik ¹, Maja Sandve ¹, Zara Hannoun ¹, Martha Eimstad Haugstøyl ¹, Inês Cardoso ¹, Sarah Vollmers ¹, Anja Ruppelt Oldenburg ¹, Luz Maria Mora-Velandia ¹, Camilla Sletten ¹, Giulia Malachin ¹, Artur Cieslar-Pobuda ¹, Liliane Christ ¹, Pimthanya Wanichawan ¹, Dennis Clement ¹, Michelle Lu Saetersmoen ¹, Frida Loe Haugen ¹, Amanda Malene Ruud ¹, Julia Mayumi Ino ¹, Pranav Oberoi ¹, Anders Holm ¹, Emilie Gauthy ¹, Namir Jafar Hassan ¹, Sylvie Pollmann ¹, Luise Ullrike Weigand ¹

Margherita Boieri ¹, Justyna Kmiecik ¹, Maja Sandve ¹

¹Zelluna ASA, Oslo, Norway.

⁰Zelluna ASA, Oslo, Norway.

Immunotherapy Advances +

|

2 de enero de 2026

|

2 de enero de 2026

Videos de Experimentos Relacionados

Contact us if these videos are not relevant.

Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model

Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model

Published on: February 10, 2023

A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells

A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells

Published on: November 12, 2019

High-Content Screening Assay for the Identification of Antibody-Dependent Cellular Cytotoxicity Modifying Compounds

High-Content Screening Assay for the Identification of Antibody-Dependent Cellular Cytotoxicity Modifying Compounds

Published on: August 18, 2023

See all related videos

Resumen

No abstract available on PubMed

Palabras clave:

En el caso de las personas físicas: Células TCR-NK Mejora de la afinidad inmunoterapia tumores sólidos

Videos de Experimentos Relacionados

Contact us Si estos videos no son relevantes.

Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model

Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model

Published on: February 10, 2023

A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells

A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells

Published on: November 12, 2019

High-Content Screening Assay for the Identification of Antibody-Dependent Cellular Cytotoxicity Modifying Compounds

High-Content Screening Assay for the Identification of Antibody-Dependent Cellular Cytotoxicity Modifying Compounds

Published on: August 18, 2023

See all related videos

Share

X
Facebook
LinkedIn
YouTube

ABOUT JoVE

Overview
Leadership
Blog
JoVE Help Center

AUTHORS

Publishing Process
Editorial Board
Scope & Policies
Peer Review
FAQ
Submit

LIBRARIANS

Testimonials
Subscriptions
Access
Resources
Library Advisory Board
FAQ

RESEARCH

JoVE Journal
Methods Collections
JoVE Encyclopedia of Experiments
Archive

EDUCATION

JoVE Core
JoVE Business
JoVE Science Education
JoVE Lab Manual
Faculty Resource Center
Faculty Site

Terms & Conditions of Use
Privacy Policy
Policies